Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Juno (formerly folate receptor 4, FOLR4) is a GPI-anchored cell-surface protein essential for the recognition and fusion of sperm and egg in mammals. It acts as the egg receptor for Izumo1, the corresponding sperm surface protein. Despite sequence homology with classical folate receptors, Juno does not bind folate and cannot mediate folate uptake. Its function is critical for female fertility, and genetic ablation results in infertility due to failed sperm-egg fusion[3][5]. In mouse, Folr4/Juno is also expressed on regulatory T cells and explored for tumor immunotherapy, though these roles are not established in humans. Juno (Folate receptor 4, FOLR4) is an essential receptor for sperm-egg fusion in mammals, but it does not perform typical folate transport. Its main biological role is in reproduction, making it a unique receptor outside classical folate receptor family functions[3][5].
For targeting fertility, Juno functions as the receptor for sperm protein Izumo1; modulating the Juno-Izumo1 interaction could hypothetically impact fertilization. As an immunotherapy target, mechanisms relate to cell-surface recognition in mouse regulatory T cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Juno (egg Izumo receptor) (Juno).